Injective (INJ) is trading at $5.49, with its relative strength index at 65 and the price sitting on the upper Bollinger Band. Technical analysis points to a move to $6.80 within the next 60 days, and derivatives data suggests the token's accumulation phase has wrapped up.
Why the $5.49 level matters
A reading of 65 on the RSI puts INJ in bullish territory but short of overbought — room to run, in other words. The upper Bollinger Band placement often signals momentum is strong, especially when backed by volume. For traders, the combination of these two indicators at the current price creates a setup that historically precedes breakout moves. The $6.80 target represents roughly a 24% gain from here, a figure that aligns with the typical price extension after a Bollinger Band squeeze.
Accumulation phase signals from derivatives
Derivatives data tells a similar story. The numbers point to a completed accumulation phase, meaning that large holders and institutional players have likely been buying INJ over recent weeks without pushing the spot price into a runaway rally. When accumulation ends, the next phase is usually a markup period where prices climb more steadily. The derivatives data doesn't name specific traders or exchanges — just the aggregate pattern — but the signal is clear enough for chart watchers.
What the 60-day window means
The forecast of $6.80 in 60 days gives the market a concrete timeline. It's not a vague “soon” but a defined period that traders can use to set options or plan exits. The 60-day horizon also lines up with typical post-accumulation cycles in altcoin markets. Whether INJ hits that number depends on broader market conditions, but the technical setup is specific: price on the upper band, RSI in the mid-60s, and a completed accumulation phase. Those three factors rarely appear together without a follow-through move.
